| 产品名称： | CV-1/EBNA-1 |
|---|---|
| 商品货号： | TS212313 |
| Organism： | Cercopithecus aethiops |
| Tissue： | kidney |
| Product Format： | frozen |
| Morphology： | fibroblast |
| Culture Properties： | adherent |
| Biosafety Level： | 2 xa0Cells contain herpesvirus
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | normal |
| Age： | 141 days |
| Gender： | male |
| Applications： | transfection host |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Clinical Data： | male |
| Genes Expressed： | Epstein-Barr nuclear antigen 1 (EBNA-1),Expression of EBNA-1 permits episomal replication of expression vectors such as pDC406 that contain the EBV origin of replication. |
| Cellular Products： | Epstein-Barr nuclear antigen 1 (EBNA-1) |
| Comments： | Expression of EBNA-1 permits episomal replication of expression vectors such as pDC406 that contain the EBV origin of replication. The cells can be used as host for expression of transfected DNA. The line was derived from CV-1 (ATCC CCL-70) by transfection with a plasmid encoding Epstein Barr Virus nuclear antigen 1 (EBNA-1). |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Protocol: Remove old medium, add fresh 0.25% trypsin solution for 2 to 3 minutes, remove trypsin and let culture stand for 5 to 10 minutes at room temperature. Add fresh medium, aspirate and dispense into new flasks. Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended Medium Renewal: Twice per week |
| Cryopreservation： | Freeze medium: Culture medium, 95%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions： | Temperature: 37.0°C |
| Name of Depositor： | Immunex Corporation |
| Deposited As： | Cercopithecus aethiops |
| U.S. Patent Number： | |
| References： | McMahan CJ, et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10: 2821-2832, 1991. PubMed: 1833184 Gearing DP. Receptor for oncostatin M and leukemia inhibitory factor. US Patent 5,262,522 dated Nov 16 1993 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | CV-1/EBNA-1 |
|---|---|
| 商品货号： | TS212313 |
| Organism： | Cercopithecus aethiops |
| Tissue： | kidney |
| Product Format： | frozen |
| Morphology： | fibroblast |
| Culture Properties： | adherent |
| Biosafety Level： | 2 xa0Cells contain herpesvirus
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | normal |
| Age： | 141 days |
| Gender： | male |
| Applications： | transfection host |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Clinical Data： | male |
| Genes Expressed： | Epstein-Barr nuclear antigen 1 (EBNA-1),Expression of EBNA-1 permits episomal replication of expression vectors such as pDC406 that contain the EBV origin of replication. |
| Cellular Products： | Epstein-Barr nuclear antigen 1 (EBNA-1) |
| Comments： | Expression of EBNA-1 permits episomal replication of expression vectors such as pDC406 that contain the EBV origin of replication. The cells can be used as host for expression of transfected DNA. The line was derived from CV-1 (ATCC CCL-70) by transfection with a plasmid encoding Epstein Barr Virus nuclear antigen 1 (EBNA-1). |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Protocol: Remove old medium, add fresh 0.25% trypsin solution for 2 to 3 minutes, remove trypsin and let culture stand for 5 to 10 minutes at room temperature. Add fresh medium, aspirate and dispense into new flasks. Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended Medium Renewal: Twice per week |
| Cryopreservation： | Freeze medium: Culture medium, 95%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions： | Temperature: 37.0°C |
| Name of Depositor： | Immunex Corporation |
| Deposited As： | Cercopithecus aethiops |
| U.S. Patent Number： | |
| References： | McMahan CJ, et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10: 2821-2832, 1991. PubMed: 1833184 Gearing DP. Receptor for oncostatin M and leukemia inhibitory factor. US Patent 5,262,522 dated Nov 16 1993 |
